Cargando…

Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study

SIMPLE SUMMARY: Embryonic mortality (EM) is one of the leading causes of infertility in modern breeding. This results in a reduction in reproductive performance, significant economic losses and can affect the environmental impact. The introduction of intensive breeding systems and the selection of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacelli, Corrado, Barile, Vittoria Lucia, Sabia, Emilio, Casano, Anna Beatrice, Braghieri, Ada, Martina, Valeria, Barbato, Olimpia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597821/
https://www.ncbi.nlm.nih.gov/pubmed/36290208
http://dx.doi.org/10.3390/ani12202822
_version_ 1784816183410688000
author Pacelli, Corrado
Barile, Vittoria Lucia
Sabia, Emilio
Casano, Anna Beatrice
Braghieri, Ada
Martina, Valeria
Barbato, Olimpia
author_facet Pacelli, Corrado
Barile, Vittoria Lucia
Sabia, Emilio
Casano, Anna Beatrice
Braghieri, Ada
Martina, Valeria
Barbato, Olimpia
author_sort Pacelli, Corrado
collection PubMed
description SIMPLE SUMMARY: Embryonic mortality (EM) is one of the leading causes of infertility in modern breeding. This results in a reduction in reproductive performance, significant economic losses and can affect the environmental impact. The introduction of intensive breeding systems and the selection of high-production animals have accentuated EM, also in buffalo. This study aimed to verify if GnRH treatment at 35 days after artificial insemination of subjects identified at risk of embryonic mortality on the basis of pregnancy-associated glycoprotein (PAG) levels, could reduce EM in buffalo. ABSTRACT: The aim of the study was to evaluate the effects of GnRH administrated at day 35 after artificial insemination (AI) on the reproductive performance of buffalo cows. In ten buffalo farms in the period January–February, 481 buffalo cows were subjected to estrus synchronization protocol and fixed-time artificial insemination (Ovsynch–TAI program). Radioimmunoassays (RIA) for pregnancy-associated glycoproteins (PAGs) were used to detect pregnancy at day 28 after AI (cut-off value: ≥1 ng/mL). Among pregnant subjects, those with PAG values between 1 and 2.5 ng/mL were considered at risk of embryonic mortality (EM) and were assigned into two groups: treated (T; n = 57) control (C; n = 57). Treated buffaloes received 0.01 mg of buserelin acetate intramuscularly on day 35 after AI, whereas control buffaloes received no treatment. The pregnancy diagnosis was confirmed at day 60 through PAGs level and rectal palpation. The treatment with GnRH had a significant effect (p < 0.001) in reducing EM. Between days 28 and 60 after AI, the animals that experienced EM were only 2/57 in the T group, while were 13/57 in the C group. Moreover, GnRH treatment produced a significant increase (p < 0.001) in the PAG concentration between day 28 and day 60. Administration of GnRH at day 35 after AI in animals considered at risk of low embryo survival based on PAG levels allowed a reduction in pregnancy losses and improved the pregnancy rate during low-breeding season in buffalo.
format Online
Article
Text
id pubmed-9597821
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95978212022-10-27 Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study Pacelli, Corrado Barile, Vittoria Lucia Sabia, Emilio Casano, Anna Beatrice Braghieri, Ada Martina, Valeria Barbato, Olimpia Animals (Basel) Article SIMPLE SUMMARY: Embryonic mortality (EM) is one of the leading causes of infertility in modern breeding. This results in a reduction in reproductive performance, significant economic losses and can affect the environmental impact. The introduction of intensive breeding systems and the selection of high-production animals have accentuated EM, also in buffalo. This study aimed to verify if GnRH treatment at 35 days after artificial insemination of subjects identified at risk of embryonic mortality on the basis of pregnancy-associated glycoprotein (PAG) levels, could reduce EM in buffalo. ABSTRACT: The aim of the study was to evaluate the effects of GnRH administrated at day 35 after artificial insemination (AI) on the reproductive performance of buffalo cows. In ten buffalo farms in the period January–February, 481 buffalo cows were subjected to estrus synchronization protocol and fixed-time artificial insemination (Ovsynch–TAI program). Radioimmunoassays (RIA) for pregnancy-associated glycoproteins (PAGs) were used to detect pregnancy at day 28 after AI (cut-off value: ≥1 ng/mL). Among pregnant subjects, those with PAG values between 1 and 2.5 ng/mL were considered at risk of embryonic mortality (EM) and were assigned into two groups: treated (T; n = 57) control (C; n = 57). Treated buffaloes received 0.01 mg of buserelin acetate intramuscularly on day 35 after AI, whereas control buffaloes received no treatment. The pregnancy diagnosis was confirmed at day 60 through PAGs level and rectal palpation. The treatment with GnRH had a significant effect (p < 0.001) in reducing EM. Between days 28 and 60 after AI, the animals that experienced EM were only 2/57 in the T group, while were 13/57 in the C group. Moreover, GnRH treatment produced a significant increase (p < 0.001) in the PAG concentration between day 28 and day 60. Administration of GnRH at day 35 after AI in animals considered at risk of low embryo survival based on PAG levels allowed a reduction in pregnancy losses and improved the pregnancy rate during low-breeding season in buffalo. MDPI 2022-10-18 /pmc/articles/PMC9597821/ /pubmed/36290208 http://dx.doi.org/10.3390/ani12202822 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pacelli, Corrado
Barile, Vittoria Lucia
Sabia, Emilio
Casano, Anna Beatrice
Braghieri, Ada
Martina, Valeria
Barbato, Olimpia
Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study
title Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study
title_full Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study
title_fullStr Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study
title_full_unstemmed Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study
title_short Use of GnRH Treatment Based on Pregnancy-Associated Glyco-Proteins (PAGs) Levels as a Strategy for the Maintenance of Pregnancy in Buffalo Cows: A Field Study
title_sort use of gnrh treatment based on pregnancy-associated glyco-proteins (pags) levels as a strategy for the maintenance of pregnancy in buffalo cows: a field study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597821/
https://www.ncbi.nlm.nih.gov/pubmed/36290208
http://dx.doi.org/10.3390/ani12202822
work_keys_str_mv AT pacellicorrado useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy
AT barilevittorialucia useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy
AT sabiaemilio useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy
AT casanoannabeatrice useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy
AT braghieriada useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy
AT martinavaleria useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy
AT barbatoolimpia useofgnrhtreatmentbasedonpregnancyassociatedglycoproteinspagslevelsasastrategyforthemaintenanceofpregnancyinbuffalocowsafieldstudy